- Home
- JANX vs PENG Comparison
JANX vs PENG Comparison
Compare JANX & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- PENG
- Stock Information
- Founded
- JANX 2017
- PENG 1988
- Country
- JANX United States
- PENG United States
- Employees
- JANX N/A
- PENG N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- PENG Semiconductors
- Sector
- JANX Health Care
- PENG Technology
- Exchange
- JANX Nasdaq
- PENG Nasdaq
- Market Cap
- JANX 1.4B
- PENG 1.3B
- IPO Year
- JANX 2021
- PENG 2017
- Fundamental
- Price
- JANX $27.01
- PENG $21.93
- Analyst Decision
- JANX Strong Buy
- PENG Strong Buy
- Analyst Count
- JANX 11
- PENG 8
- Target Price
- JANX $76.55
- PENG $27.50
- AVG Volume (30 Days)
- JANX 927.5K
- PENG 1.6M
- Earning Date
- JANX 11-05-2025
- PENG 10-07-2025
- Dividend Yield
- JANX N/A
- PENG N/A
- EPS Growth
- JANX N/A
- PENG N/A
- EPS
- JANX N/A
- PENG 0.28
- Revenue
- JANX $439,000.00
- PENG $1,368,794,000.00
- Revenue This Year
- JANX N/A
- PENG $11.41
- Revenue Next Year
- JANX $91.66
- PENG $12.79
- P/E Ratio
- JANX N/A
- PENG $78.07
- Revenue Growth
- JANX N/A
- PENG 16.91
- 52 Week Low
- JANX $21.73
- PENG $14.20
- 52 Week High
- JANX $71.71
- PENG $29.80
- Technical
- Relative Strength Index (RSI)
- JANX 59.54
- PENG 36.53
- Support Level
- JANX $25.62
- PENG $21.75
- Resistance Level
- JANX $27.70
- PENG $23.13
- Average True Range (ATR)
- JANX 1.56
- PENG 0.97
- MACD
- JANX 0.30
- PENG -0.40
- Stochastic Oscillator
- JANX 69.68
- PENG 9.54
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.